- Home
- AIRG vs GNTA Comparison
AIRG vs GNTA Comparison
Compare AIRG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- GNTA
- Stock Information
- Founded
- AIRG 1995
- GNTA 2014
- Country
- AIRG United States
- GNTA Italy
- Employees
- AIRG N/A
- GNTA N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIRG Technology
- GNTA Health Care
- Exchange
- AIRG Nasdaq
- GNTA Nasdaq
- Market Cap
- AIRG 79.4M
- GNTA 75.9M
- IPO Year
- AIRG 2016
- GNTA 2021
- Fundamental
- Price
- AIRG $6.87
- GNTA $3.81
- Analyst Decision
- AIRG Strong Buy
- GNTA Strong Buy
- Analyst Count
- AIRG 2
- GNTA 1
- Target Price
- AIRG $11.75
- GNTA $25.00
- AVG Volume (30 Days)
- AIRG 36.3K
- GNTA 10.9K
- Earning Date
- AIRG 02-27-2025
- GNTA 01-01-0001
- Dividend Yield
- AIRG N/A
- GNTA N/A
- EPS Growth
- AIRG N/A
- GNTA N/A
- EPS
- AIRG N/A
- GNTA N/A
- Revenue
- AIRG $55,586,000.00
- GNTA N/A
- Revenue This Year
- AIRG $14.12
- GNTA N/A
- Revenue Next Year
- AIRG $15.47
- GNTA N/A
- P/E Ratio
- AIRG N/A
- GNTA N/A
- Revenue Growth
- AIRG N/A
- GNTA N/A
- 52 Week Low
- AIRG $3.71
- GNTA $2.20
- 52 Week High
- AIRG $10.34
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- AIRG 42.99
- GNTA 39.48
- Support Level
- AIRG $5.90
- GNTA $3.52
- Resistance Level
- AIRG $7.59
- GNTA $4.50
- Average True Range (ATR)
- AIRG 0.53
- GNTA 0.34
- MACD
- AIRG 0.00
- GNTA -0.02
- Stochastic Oscillator
- AIRG 37.74
- GNTA 24.37
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.